Signalling through Class I PI3Ks in mammalian cells

Area of Science:

• Cellular Biology
• Molecular Signaling
• Biochemistry

Background:

• Class I phosphoinositide 3-kinases (PI3Ks) are central to signal transduction pathways activated by cell-surface receptors.
• These pathways regulate fundamental cellular processes including growth, survival, proliferation, and movement.
• PI3Ks synthesize phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3), a key second messenger.

Purpose of the Study:

• To elucidate the complex signaling web downstream of PI3K activation.
• To identify key effectors linking PI3K activity to specific cellular responses.
• To explore the therapeutic potential of targeting the Class I PI3K pathway.

Main Methods:

• Analysis of structural adaptations in PI3K enzymes and their regulation by cell-surface receptors.
• Investigation of PtdIns(3,4,5)P3 and PtdIns(3,4)P2 as messenger molecules.
• Utilizing transgenic mouse models and PI3K isoform-selective inhibitors.

Main Results:

• Identified key downstream effectors including Rho/Arf family GTPases and protein kinase B (PKB).
• Highlighted the involvement of PI3K pathway components (e.g., PI3Kalpha, PTEN) in oncogenesis and tumor suppression.
• Demonstrated isoform-specific roles of PI3Kalpha, PI3Kbeta, PI3Kdelta, and PI3Kgamma in growth, metabolism, thrombosis, and inflammation.

Conclusions:

• The Class I PI3K signaling pathway is a critical regulator of cellular fate and function.
• Dysregulation of this pathway is implicated in various pathologies, including cancer and inflammatory diseases.
• Targeting specific PI3K isoforms represents a promising strategy for novel therapeutic development.